We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Nihon Kohden

Major product line for clinical diagnostics includes both automatic and semiautomatic hematology analyzers. The produ... read more Featured Products: More products

Download Mobile App




Nihon Kohden America Launches New Series of Bedside Monitoring Systems

By HospiMedica International staff writers
Posted on 06 Apr 2022

Nihon Kohden America (Irvine, CA, USA) has announced the expansion of the Life Scope G Series with the US market introduction of Life Scope G5 and G5Max, a new series of bedside monitoring systems. More...

Created by clinicians, for clinicians- these patient monitors provide more data, more insights, and more efficiency for better patient outcomes.

The advanced features of Life Scope G5 and G5Max combine fully optimized, adaptable monitors with an enterprise level server and software applications customized to the needs of clinicians. With consistent user interfaces that are easy to use and streamline workflows, clinicians are empowered to spend more time with their patients and less with technology.

The Life Scope G5 is configured as an all-in-one system with a transport monitor nested in the back of the unit and is available in a 12.1” display. For a larger high-performance screen, the G5Max is available in 15.6” with a true flat tempered glass front. Both Life Scope G5 and G5Max allow users to configure the alarms to meet their clinical needs and reduce alarm fatigue. The Life Scope G5 and G5Max offer advanced EGG parameter monitoring such as continuous QTc or QRSd, advanced atrial fibrillation algorithm, enhanced review capability ST analysis and event recall.

“Patients are our top priority at Nihon Kohden America, when we succeed, patients everywhere heal faster,” said Eiichi (Eddie) Tanaka, President and CEO at Nihon Kohden America, “We designed the expansion of the Life Scope G Series to help accomplish one critical goal: allow clinicians to spend more time with their patients and less with technology.”

Related Links:
Nihon Kohden America 


Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Glucose Meter
StatStrip®
Monitor/Defibrillator
Zenix
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image Credit: Adobe Stock

AI Platform Personalizes Support Between Visits for Cancer Survivors

Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more

Medical Imaging

view channel
Image: Annotation platform for pixel-level labeling of free-text findings in 3D chest CT. (Baharoon M, Luo L, Moritz M, et al. ReXGroundingCT: A 3D chest CT dataset for segmentation of findings from free-text reports. NEJM AI. 2026;3(7). doi:10.1056/AIdbp2501220.)

Public Chest CT Dataset Supports Explainable AI in Diagnostic Radiology

Chest computed tomography scans generate complex three-dimensional images that can be difficult for artificial intelligence systems to explain clearly. Clinicians need to verify AI findings before using... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: The proposed acquisition would add NeoCast, an investigational next-generation liquid embolic technology for chronic subdural hematoma (cSDH), to Terumo Neuro’s neurovascular portfolio. (Photo courtesy of Arsenal Medical)

Terumo Neuro Acquisition Advances Liquid Embolic Technology for Chronic Subdural Hematoma

Terumo Neuro (Aliso Viejo, CA, USA) signed an agreement to acquire Arsenal Medical Inc. (Waltham, MA, USA), a privately held, clinical-stage biomaterials company. The proposed acquisition would add NeoCast,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.